Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 17

1.

Impact of ASC-H terminology on the detection of HSILs in medically underserved California women.

Howell LP, Gurusinghe S, Tabnak F.

Diagn Cytopathol. 2009 Feb;37(2):103-10. doi: 10.1002/dc.20965.

PMID:
19021201
2.

Racial and ethnic disparities in cervical cancer incidence rates in the United States, 1992-2003.

McDougall JA, Madeleine MM, Daling JR, Li CI.

Cancer Causes Control. 2007 Dec;18(10):1175-86. Epub 2007 Sep 6.

PMID:
17805982
3.

ACOG Practice Bulletin number 66, September 2005. Management of abnormal cervical cytology and histology.

American College of Obstetricians and Gynecologists.

Obstet Gynecol. 2005 Sep;106(3):645-64. No abstract available.

PMID:
16135610
4.

Exploring access to cancer control services for Asian-American and Pacific Islander communities in Southern California.

Tanjasiri SP, Tran JH, Kagawa-Singer M, Foo MA, Foong HL, Lee SW, Nguyen TU, Rickles J, Wang JS.

Ethn Dis. 2004 Summer;14(3 Suppl 1):S14-9.

PMID:
15682767
5.

Interventions to improve follow-up of abnormal findings in cancer screening.

Bastani R, Yabroff KR, Myers RE, Glenn B.

Cancer. 2004 Sep 1;101(5 Suppl):1188-200. Review.

6.

Processes of care in cervical and breast cancer screening and follow-up--the importance of communication.

Zapka JG, Puleo E, Taplin SH, Goins KV, Ulcickas Yood M, Mouchawar J, Somkin C, Manos MM.

Prev Med. 2004 Jul;39(1):81-90.

PMID:
15207989
7.

Is the promise of cancer-screening programs being compromised? Quality of follow-up care after abnormal screening results.

Yabroff KR, Washington KS, Leader A, Neilson E, Mandelblatt J.

Med Care Res Rev. 2003 Sep;60(3):294-331. Review.

PMID:
12971231
8.

2001 Consensus Guidelines for the management of women with cervical cytological abnormalities.

Wright TC Jr, Cox JT, Massad LS, Twiggs LB, Wilkinson EJ; ASCCP-Sponsored Consensus Conference.

JAMA. 2002 Apr 24;287(16):2120-9. Review.

PMID:
11966387
9.

Community-based cancer screening for underserved women: design and baseline findings from the Breast and Cervical Cancer Intervention Study.

Hiatt RA, Pasick RJ, Stewart S, Bloom J, Davis P, Gardiner P, Johnston M, Luce J, Schorr K, Brunner W, Stroud F.

Prev Med. 2001 Sep;33(3):190-203.

PMID:
11522160
10.
11.

Time trends in late-stage diagnosis of cervical cancer. Differences by race/ethnicity and income.

Mitchell JB, McCormack LA.

Med Care. 1997 Dec;35(12):1220-4. No abstract available.

PMID:
9413310
12.

An examination of differential follow-up rates in cervical cancer screening.

Fox P, Amsberger P, Zhang X.

J Community Health. 1997 Jun;22(3):199-209.

PMID:
9178119
13.

Follow-up of abnormal Papanicolaou smears among women of different races.

Carey P, Gjerdingen DK.

J Fam Pract. 1993 Dec;37(6):583-7.

PMID:
8245810
14.
15.

Determinants of late stage diagnosis of breast and cervical cancer: the impact of age, race, social class, and hospital type.

Mandelblatt J, Andrews H, Kerner J, Zauber A, Burnett W.

Am J Public Health. 1991 May;81(5):646-9. Erratum in: Am J Public Health 1991 Aug;81(8):980.

16.

Cervical cancer control: a study of morbidity and mortality trends over a twenty-one-year period.

Christopherson WM, Lundin FE Jr, Mendez WM, Parker JE.

Cancer. 1976 Sep;38(3):1357-66.

17.

Does screening by "Pap" smears help prevent cervical cancer? A case-control study.

Clarke EA, Anderson TW.

Lancet. 1979 Jul 7;2(8132):1-4.

PMID:
87887

Supplemental Content

Support Center